Join
Live feed
·
PRReleasevia Quantisnow
GeneDx Holdings Corp. logo

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

ByQuantisnow·Wall Street's wire, on your screen.
WGS· GeneDx Holdings Corp.
Technology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WGS (GeneDx Holdings Corp.) and more on Quantisnow.